In addition to NSCLC, the overexpression of ABCC1, also known as multidrug resistance protein 1 (MRP1), has been associated with breast, ovarian, prostate, colorectal, and pancreatic cancers [2]. Here, ABCC1 is linked to pancreatic neoplasm.